| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05477576 | Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET… | GEP-NET | Recruiting |
| Phase 1/2 | |||
| NCT06726161 | Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify… | Hepatocellular Carcinoma (HCC) | Recruiting |
| NCT06590857 | Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or… | Metastatic Breast Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT07165132 | Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. | GEP-NET | Recruiting |
| NCT05595460 | Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC | SCLC,Extensive Stage | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT07671092 | Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC | Metastatic Urothelial Carcinoma | Not Yet Recruiting |
| NCT07671417 | Imaging Study in Metastatic Clear Cell RCC. | Metastatic Clear Cell Renal Cell Carcinoma | Not Yet Recruiting |